Zu den Inhalten springen
Interner Bereich Raumbelegung
deutsch  english  türk
Schrift größer


Prof. Dr. med. Manfred Hensel
Stand 26.1.11

Originalarbeiten mit Erst- oder Letztautorenschaft

Manfred Hensel, Armin Goetzenich, Thomas Lutz, Albrecht Stoehr, Arend Moll,
Jürgen Rockstroh, Nicola Hanhoff, Hans Jäger, Franz Mosthaf. HIV und Krebs in Deutschland.
Deutsches Ärzteblatt 2011, im Druck

Kornacker M, Kornacker B, Schmitt C, Leo E, Ho AD, Hensel M.
Commercial LightCycler(R)-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
Ann Hematol. 2009 Jan;88(1):43-50. Epub 2008 Jul 18.

Hensel, M, Zoz M, Ho AD.
Complementary and alternative medicine in patients with chronic lymphocytic leukemia.
Support Care Cancer. 2009 Jan;17(1):47-52. Epub 2008 May 6.

Schweizer C, Reu FJ, Ho AD, Hensel M.
Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Ann Hematol. 2007 Oct;86(10):711-7. Epub 2007 Jul 11.

Krämer A, Reiter A, Kruth J, Erben P, Hochhaus A, Müller M, Cross NC, Jones AV, Ho AD, Hensel M.
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.
Lancet Oncol. 2007 Jul;8(7):658-60. No abstract available.

Hensel M, Dreger P, Ho AD.
IgM-Gammopathie: Differentialdiagnose, Klinik und Therapie.
Dtsch Arztebl 2007; 104(26): A-1907 / B-1684 / C-1620

Hensel M, Zoz M, Giesecke C, Benner A, Neben K, Jauch A, Stilgenbauer S, Ho AD, Krämer A.
High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.
Int J Cancer. 2007 Sep 1;121(5):978-83.

Ho AD, Hensel M.
Pentostatin and purine analogs for indolent lymphoid malignancies.
Future Oncol. 2006 Apr;2(2):169-83. Review.

Ho AD, Hensel M.
Pentostatin for the treatment of indolent lymphoproliferative disorders.
Semin Hematol. 2006 Apr;43(2 Suppl 2):S2-10. Review.

Hensel M, Villalobos M, Kornacker M, Krasniqi F, Ho AD.
Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
Clin Lymphoma Myeloma. 2005 Sep;6(2):131-5.

Hensel M, Buss EC, Tiemann M, Parwaresch R, Libicher M, Fruehauf S, Ho AD.
Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndrome.
Eur J Haematol. 2004 Mar;72(3):217-21.

Hensel M, Kornacker M, Yammeni S, Egerer G, Ho AD.
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
Br J Haematol. 2003 Aug;122(4):600-6.
PMID: 12899715 [PubMed - indexed for

Hensel M, Ho AD.
Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
Am J Hematol. 2003 May;73(1):37-40.

Hensel M, Ho AD, Bastert G, Schneeweiss A.
Prognostic markers for survival after high-dose chemotherapy with autologous stem-cell transplantation for breast cancer.
Ann Oncol. 2003 Feb;14(2):341. No abstract available.

Hensel M, Fiehn C, Ho AD.
[Stem cell transplantation in primary systemic vasculitis]
Med Klin (Munich). 2003 Jan 15;98(1):13-8. Review. German.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD.
P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.
Int J Cancer. 2002 Jul 20;100(3):290-6.

Hensel M, Egerer G, Schneeweiss A, Goldschmidt H, Ho AD.
Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation.
Ann Oncol. 2002 Feb;13(2):209-17.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Kornacker M, Solomayer E, Haas R, Bastert G, Ho AD.
Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.
Stem Cells. 2002;20(1):32-40.

Schneeweiss A*, Hensel M*, Goerner R, Khbeis T, Hohaus S, Egerer G, Solomayer E, Haas R, Grischke EM, Bastert G, Ho AD.
Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer. (*shared first author)
Stem Cells. 2001;19(2):151-60.

Hensel M, Breitbart A, Ho AD.
Autologous hematopoietic stem-cell transplantation for Behçet's disease with pulmonary involvement.
N Engl J Med. 2001 Jan 4;344(1):69. No abstract available

© Diakonissen Speyer-Mannheim